ARS Pharmaceuticals (SPRY) to Report Q2 Earnings on August 13
SPRY ARS Pharmaceuticals Inc
$6.06 +1.85%
View chart & analysis → 
- 1ARS Pharmaceuticals (SPRY) will release its second-quarter results on August 13, 2026.
- 2Consensus calls for Q2 revenue of $31.32 million and EPS of -$0.49.
- 3The full-year revenue estimate has been revised down over the past 90 days, from $146.99 million to $139.71 million.
This 3-line summary is compiled from the report below.
GuruFocus.com +1 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다